We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Schedule an appointment today

Find University Hospitals Doctors

Kevin Kilgallon, MD

Kevin Kilgallon, MD


Pediatric Critical Care Medicine, Emergency Medicine

Not Accepting New Patients

Primary Location

UH Rainbow Babies and Children's Hospital
11100 Euclid Ave
Cleveland, OH 44106

Schedule an Appointment



  • Assistant Professor, CWRU School of Medicine

Kevin Kilgallon, MD is a pediatric cardiac intensivist. His academic and clinical interests include extracorporeal life support, cardiac critical care, and medical education. His goal is to provide excellent clinical care of his patients and their families in the cardiac ICU, and to push the boundaries of knowledge of extracorporeal support knowledge through both teaching and research.


  • Cardiac Critical Care
  • Extracorporeal Membrane Oxygenation (ECMO)
  • Mechanical Circulatory Support

Languages Spoken


Office Locations

UH Rainbow Babies and Children's Hospital

11100 Euclid Ave
Cleveland, OH 44106

Certifications & Memberships

  • Pediatric Critical Care Medicine - American Board of Pediatrics
  • Pediatrics - American Board of Pediatrics


Fellowship | ECMO (Extracorporeal Membrane Oxygenation)
ECMO (Extracorporeal Membrane Oxygenation) - Children's Hospital Colorado - Anschutz Medical Campus (2021 - 2022)

Fellowship | Pediatric Critical Care Medicine
Pediatric Critical Care Medicine - Children's Hospital Colorado - Anschutz Medical Campus (2018 - 2021)

Residency | Pediatrics
Pediatrics - Nationwide Children's Hospital (2015 - 2018)

Medical Education | Medicine
Medicine - University Of Illinois School Of Medicine, Rockford (2015)

Washington University In St Louis (2010)

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Kevin Kilgallon did not disclose any Outside Relationships with Industry.